Patent Assignment
Reel/Frame 028357/0123
Patent Security Agreement
Recorded: 2012-06-11
Pages: 11
Assignors
QUARK PHARMACEUTICALS, INC.
Executed: 2011-07-14
Q.B.I. ENTERPRISES LTD.
Executed: 2011-07-14
Assignee
NITTO DENKO CORPORATION
HERBIS 2-5-25 UMEDA, KITA-KU, OSAKA, 530-0001, JAPAN
Covered Properties
(3)
Oligonucleotide Compounds Comprising Non-Nucleotide Overhangs
PCT:
PCT/US2011/020298 ↗
Modulation of TIMP1 and TIMP2 Expression
PCT:
PCT/US2011/053496 ↗
Composition of Anti-ENDO180 Antibodies and Methods of Use for the Treatment of Cancer and Fibrotic Diseases
Related Assignments
(5)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Sep 8, 2011
From: FEINSTEIN, ELENA
To: QUARK PHARMACEUTICALS, INC.
Reel/Frame 026873/0815 →
License
Jun 11, 2012
From: QUARK PHARMACEUTICALS, INC.; Q.B.I. ENTERPRISES LTD.
To: NITTO DENKO CORPORATION
Reel/Frame 028356/0410 →
Assignment of Assignor's Interest
Sep 27, 2012
From: QUARK PHARMACEUTICALS, INC.
To: NITTO DENKO CORPORATION
Reel/Frame 029039/0292 →
Release of Security Interest in Patents
Oct 17, 2013
From: NITTO DENKO CORPORATION
To: QUARK PHARMACEUTICALS, INC.; Q.B.I. ENTERPRISES LTD.
Reel/Frame 031434/0671 →
Assignment of Assignor's Interest
Jan 5, 2022
From: QUARK PHARMACEUTICALS, INC.
To: ONCOMATRYX BIOPHARMA, S.L.
Reel/Frame 058547/0932 →